Medicine

Reduction of experimental laser-induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor

T. Kohri, M. Moriwaki, M. Nakajima, Hitoshi Tabuchi, K. Shiraki

2003.10.28GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

DOI: 10.1007/s00417-003-0761-2

tlooto Summary

MMP-2 played a role in laser-induced CNV development, and administration of BPHA reduced the experimental CNVs, and the effect appeared to be dose-dependent.

Abstract

Abstract is not available.

Citation format

KOHRI, T., et al. Reduction of experimental laser-induced choroidal neovascularization by orally administered BPHA, a selective metalloproteinase inhibitor. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2003, 241: 943–952.